Molecular Diagnostics
Biomarker Predicts Potential Benefit of Checkpoint Inhibitor Therapy for Brain Cancer Patients
A phosphorylated form of ERK (extracellular signal-regulated kinase) protein has been identified as a biomarker that may be used to predict which brain cancer patients might benefit from checkpoint inhibitor therapy. More...06 Dec 2021
Same Day Test Identifies Secondary Infections in COVID-19 Patients
The intensive care unit (ICU) is a dynamic environment with frequent staff-patient contact for invasive monitoring, interventions and personal care that together introduce the risk of secondary or nosocomial infection. When critically ill patients are cared for in the ICU, doctors may take deep samples from their lungs. More...02 Dec 2021
Liquid Biopsy Predicts Therapy Response in Patients with Late-Stage Throat Cancer
A liquid biopsy approach that measures levels of circulating tumor DNA (ctDNA) predicts therapy response in patients with stage III oropharyngeal squamous cell carcinoma (OPSCC) when used at an early point in the treatment procedure. More...30 Nov 2021
Serum MicroRNA Panel Predict P-Tau/Aβ42 in CSF in Alzheimer's Disease
Amyloid β (Aβ) and tau pathologies are classic characteristic features of Alzheimer’s disease (AD), and they are widely used as diagnostic biomarkers. AD pathology is characterized by the accumulation of amyloid-β (Aβ) plaques and tau neurofibrillary tangles in the brain. More...29 Nov 2021
New
Gold Member
Automatic CLIA Analyzer
Shine i9000
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
In Other News
Biomarkers Predict Disease Progression for Patients with Late-stage Brain Tumors
Siemens Introduces New Intelligent, Integrated IVD Solutions Virtually at EUROMEDLAB 2021
Blood and Saliva Samples Can Be Used to Detect Genetic Markers for Liver Cancer
Next-Generation Sequencing Impacts All Aspects of Myelodysplastic Syndrome Care
Simple Urine Test Detects Urothelial Cancers in Lynch Syndrome Patients
Same Day DNA Sequencing-Based Test Identifies Secondary Infections in COVID-19 Patients
AI Combined with Genomic Surveillance Beats Humans at Detecting Infectious Disease Outbreaks in Hospital Settings
Novel Protein Biomarkers Linked to Risk of Developing Type I Diabetes
Next-Generation Sequencing Strategy Validated for MRD Monitoring in Multiple Myeloma
POC System that Requires Single DNA Molecule for Rapid Detection of Multidrug-Resistant Pathogens Unveiled at MEDICA 2021
Icomes Lab Demonstrates World's Smallest and Lightest Electronic Pipette for PCR Testing at MEDICA 2021
Bosch Exhibits Vivalytic All-in-One Analyzer for PCR Rapid Tests at MEDICA 2021
Men with Certain Pathogenic Variants Had a Higher Incidence of Prostate Cancer
Co-Diagnostics Introduces Its Revolutionary Coprimer Technology at MEDICA 2021
MGI Tech Showcases World-First High-Throughput Automated Sample Transfer Processing System at MEDICA 2021
Biomarkers Associated with Major Bleeding in Patients with Atrial Fibrillation
Blood-Based Liquid Biopsy Identifies Prostate Cancer Patients Likely to Develop Resistance to Docetaxel Treatment
Randox Showcases Extensive Range of Revolutionary Diagnostic Analyzers at MEDICA 2021
Molbio Exhibits Its Novel POC Molecular Platform and Truenat Range of Tests at MEDICA 2021
Greiner Bio-One Exhibits Its New Generation of Sapphire Pipette Tips at MEDICA 2021
LumiraDx Presents its Innovative, Next Generation Point of Care Diagnostics Platform at MEDICA 2021
Medix Biochemica Celebrates Launch of New Molecular Diagnostic Reagents Division at MEDICA 2021
Fujirebio Highlights Its Innovative IVD Testing Solutions for Today and Tomorrow at MEDICA 2021
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
